Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
132.00    -3.50 (-2.58%)
Bid:
133.00
Ask:
139.50
Spread: 6.50 (4.887%)
Market Cap: £103.58m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Board Change

23 Feb 2024 10:30

RNS Number : 1814E
Xaar PLC
23 February 2024
 

23 February 2024

Xaar plc

Board Change

Xaar plc, ("the Company" or "Xaar"), a leading inkjet printing technology group, announces today the appointment of Stuart Widdowson to the Board as a Non-Executive Director effective from 27 February 2024.

Mr Widdowson is appointed as a representative of Odyssean Capital LLP ("Odyssean"), pursuant to a relationship agreement between the Company and Odyssean. The key terms are summarised in the notes below.

Mr Widdowson is the Managing Partner of Odyssean Capital, which he founded in 2017. From 2009 until 2017, he was lead fund manager of Strategic Equity Capital plc, which experienced a turnaround in its performance and rating during his tenure. He began his career as a strategy consultant undertaking commercial due diligence and strategy projects for private equity and corporate clients, before working for HgCapital, a leading private equity investor.

As at the last practicable date the total shareholding of funds managed by Odyssean Capital was 13,175,000 ordinary shares in the Company ("Ordinary Shares") representing approximately 16.6 per cent. of the Company's share capital. Additionally, Mr Widdowson beneficially owns 25,000 Ordinary Shares and the joint venture partner of Odyssean Capital, Harwood Capital, owns 1,050,000 Ordinary Shares.

Notes:

A summary of the key terms of the Relationship Agreement is as follows:

· Xaar has granted Odyssean the right to appoint Mr Widdowson to be a Director of the Company for appointment to the Board (the "Nominated Director") for so long as Odyssean has the right to exercise at least 10% or more of the Company's ordinary shares or voting rights attaching to the ordinary shares;

· Odyssean undertakes to, inter alia: (1) conduct all transactions and relationships with any member of Xaar's group on an arm's length basis; (2) not take any action which would have the effect of preventing Xaar or any member of Xaar's group from carrying on business independently of Odyssean or its associates; (3) not influence the day-to-day running of the Company (save through Mr Widdowson's role as the Nominated Director) and (4) not vote to prevent Xaar being managed in accordance with the principles of good governance set out in the UK Corporate Governance Code; and

· the Relationship Agreement will terminate (1) on the date upon which Odyssean ceases to hold at least 10% of the ordinary shares of the Company or the voting rights attaching to the ordinary shares of the Company; (2) on six months' notice written notice by either party at any time or immediately upon written notice in the event of a material breach of the Relationship Agreement; or (3) in the event that the Company's ordinary shares cease to be listed on the Official List or another recognised UK stock exchange.

Pursuant to Listing Rule 9.6.13, it is confirmed that Mr Widdowson was a director and shareholder of Durendal Limited, a fund management business, which was wound up in 2015. His shareholding was acquired by the majority shareholder and the cash was distributed to all shareholders before the company was voluntarily liquidated.

There is no additional information required to be disclosed pursuant to Listing Rule 9.6.13 in relation to the appointment of Stuart Widdowson to the Board.

Enquiries:

Xaar plc

+44 (0) 1223 423 663 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

 

Teneo Communications

Giles Kernick

Olivia Lucas

+44 (0) 207 353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOATTMPTMTTTBFI
Date   Source Headline
27th Aug 20157:01 amRNS2015 Interim Results
26th Aug 20156:01 pmRNSHolding(s) in Company
3rd Aug 201510:25 amRNSTotal Voting Rights
8th Jul 20157:00 amRNSScheduled Trading Statement
7th Jul 20153:28 pmRNSHolding(s) in Company
1st Jul 20151:36 pmRNSBlocklisting Interim Review
1st Jul 20151:33 pmRNSTotal Voting Rights
5th Jun 20157:00 amRNSDirectorate Change
1st Jun 20151:16 pmRNSTotal Voting Rights
1st May 20151:27 pmRNSDirector Shareholding
1st May 201512:37 pmRNSTotal Voting Rights
27th Apr 201510:00 amRNSDirectorate Change
8th Apr 20153:58 pmRNSDirector/PDMR Shareholding
7th Apr 20154:33 pmRNSGrant of Options
7th Apr 20154:31 pmRNSDirector/PDMR Shareholding
31st Mar 20155:23 pmRNSTotal Voting Rights
27th Mar 201510:08 amRNSDirectorate Change
24th Mar 20152:15 pmRNSDirector/PDMR Shareholding
19th Mar 20157:00 amRNS2014 Full Year Results
3rd Mar 20159:51 amRNSTotal Voting Rights
2nd Mar 20157:00 amRNSDirector Appointment
16th Feb 20152:09 pmRNSDirectorate Change
2nd Feb 20155:52 pmRNSTotal Voting Rights
5th Jan 20157:00 amRNSAppointment of CEO
2nd Jan 201510:00 amRNSBlocklisting Interim Review
2nd Jan 201510:00 amRNSTotal Voting Rights
19th Dec 20142:34 pmRNSHolding(s) in Company
17th Dec 20147:00 amRNSTrading Update
16th Dec 20143:58 pmRNSHolding(s) in Company
15th Dec 201411:01 amRNSHolding(s) in Company
12th Dec 20149:31 amRNSHolding(s) in Company
1st Dec 20145:32 pmRNSTotal Voting Rights
27th Nov 20144:22 pmRNSHolding(s) in Company
3rd Nov 201412:34 pmRNSTotal Voting Rights
3rd Nov 201410:01 amRNSHolding(s) in Company
27th Oct 201412:48 pmRNSDirector/PDMR Shareholding
10th Oct 20149:57 amRNSHolding(s) in Company
7th Oct 20144:26 pmRNSHolding(s) in Company
6th Oct 20142:35 pmRNSHolding(s) in Company
3rd Oct 20145:12 pmRNSHolding(s) in Company
2nd Oct 20147:00 amRNSInterim Management Statement
1st Oct 20143:57 pmRNSTotal Voting Rights
30th Sep 20149:12 amRNSGrant of Options - Share Save
16th Sep 20142:56 pmRNSHolding(s) in Company
9th Sep 20143:11 pmRNSHolding(s) in Company
8th Sep 20143:02 pmRNSDirector/PDMR Shareholding
1st Sep 20145:41 pmRNSTotal Voting Rights
28th Aug 20147:00 amRNS2014 Interim Results
1st Aug 20141:11 pmRNSTotal Voting Rights
17th Jul 20147:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.